Skip to content
DataLookout
Menu

NA-LND-GCNCT07902596

Lymph Node Dissection After Neoadjuvant Therapy for Gastric and EGJ Adenocarcinoma

StatusNot Yet Recruiting
PhaseNot specified
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 1 version: 1 with changes below.

  1. Study First Submitted

Endpoints

Primary

Station-specific lymph node metastasis rates stratified by ycT and ycN categories
Timeframe: At definitive postoperative pathological assessment, generally within 30 days after gastrectomy

Secondary (2)

Station-specific lymph node metastasis rates stratified by ypT, ypN, and tumor regression grade
Numbers of examined and metastatic lymph nodes according to tumor location

Arms and interventions

E cohort

Patients with tumors whose upper margin reaches or crosses the esophagogastric junction, or whose endoscopy report explicitly describes an unclear, immediately adjacent, or involved dentate line.

U cohort

Patients with non-E tumors centered in the upper third of the stomach according to the Japanese Gastric Cancer Association anatomical classification.

M cohort

Patients with non-E tumors centered in the middle third of the stomach according to the Japanese Gastric Cancer Association anatomical classification.

L cohort

Patients with non-E tumors centered in the lower third of the stomach according to the Japanese Gastric Cancer Association anatomical classification.

Sites

8 sites in 1 country